Vertex Pharmaceuticals · Operating Cash Flow (Statement)

Latest reported$4.29Bperiod endingJun 30, 2026

VRTX TTM Cash from Operations (-$5.30M → $4.29B)

TTM operating cash flow (statement)

High-resolution chart · PNG

VRTX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-35,343,000
Mar 31, 2001	-9,619,000
Dec 31, 2000	-16,644,000
Sep 30, 2000	6,379,000
Jun 30, 2000	3,128,000
Mar 31, 2000	-32,449,000
Dec 31, 1999	-31,800,000
Sep 30, 1999	-51,800,000
Jun 30, 1999	-37,300,000
Mar 31, 1999	-33,800,000
Dec 31, 1998	-31,100,000
Sep 30, 1998	-23,800,000
Jun 30, 1998	-27,600,000
Mar 31, 1998	-18,900,000
Dec 31, 1997	-9,400,000
Sep 30, 1997	-8,800,000
Jun 30, 1997	-12,900,000
Mar 31, 1997	-34,700,000
Dec 31, 1996	-40,300,000
Sep 30, 1996	-37,100,000
Jun 30, 1996	-34,600,000
Mar 31, 1996	-19,300,000
Dec 31, 1995	-16,000,000
Sep 30, 1995	-21,700,000
Jun 30, 1995	-19,900,000
Mar 31, 1995	-16,200,000
Dec 31, 1994	-14,700,000
Sep 30, 1994	1,000,000
Jun 30, 1994	3,700,000
Mar 31, 1994	7,000,000
Dec 31, 1993	8,600,000
Sep 30, 1993	-3,200,000
Jun 30, 1993	-4,700,000
Mar 31, 1993	-5,800,000
Dec 31, 1992	-5,300,000
Sep 30, 1992	-4,200,000
Jun 30, 1992	-3,500,000